These two compounds were reported to control the activation of target cells in these autoimmune diseases, via the signal transducer and activator of transcription (STAT) subtypes in the janus kinase (JAK)-STAT pathway [89]. This evidence concerns the gene SOAT1 and autoimmune disease.